C-reactive protein inhibits increased pulmonary vascular permeability induced by fMLP in isolated rabbit lungs

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 271, Issue 2 40-2, 1996, Pages

  Abernathy, Valerie J ^a   Webster, Robert O ^a   Dahms, Thomas E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

acute lung injury; neutrophil

Indexed keywords

C REACTIVE PROTEIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; INFLAMMATION; LUNG; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; LUNG INJURY; LUNG LAVAGE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 33750741478     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.271.2.h507     Document Type: Article

References (31)

1. Albrightson, C. R., A. S. Evers, A. C. Griffin, and P. Needleman. Effect of endogenously produced leukotrienes and thromboxane on renal vascular resistance in rabbit hydronephrosis. Circ. Res. 61: 514-522, 1987.
2. Ballou, S. P., J. Buniel, and S. S. MacIntyre. Specific binding of human C-reactive protein to human monocytes in vitro. J. Immunol. 142: 2708-2713, 1989.
3. Buchta, R., M. Fridkin, M. Pontet, E. Contessi, B. Scaggiante, and D. Romeo. Modulation of human neutrophil function by C-reactive protein. Eur. J. Biochem 163: 141-146, 1987.
4. Buchta, R., M. Pontet, and M. Fridkin. Binding of C-reactive protein to human neutrophils. FEBS Lett. 211: 165-168, 1987.
5. Claus, D. R., J. Siegel, K. Petras, A. P. Osmand, and H. Gewurz. Interactions of C-reactive protein with the first component of human complement. J. Immunol. 119: 187-192, 1977.
6. Doerschuk, C. M., N. Beyers, H. O. Coxson, B. Wiggs, and J. C. Hogg. Comparison of neutrophil and capillary diameters and their relation to neutrophil sequestration in the lung. J. Appl. Physiol. 74: 3040-3045, 1993.
7. Ermert, L., H. Duncker, S. Rosseau, H. Schutte, and W. Seeger. Morphometric analysis of pulmonary intracapillary leukocyte pools in ex vivo-perfused rabbit lungs. Am. J. Physiol. 267 (Lung Cell Mol. Physiol. 11): L64-L70, 1994.
8. 4 increases pulmonary vascular permeability and pressure by different mechanisms in the rabbit. Am. Rev. Respir. Dis. 134: 229-232, 1986.
9. Ganter, U. R., R. Arcone, C. Toniatti, B. Morrone, and G. Ciliberto. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. EMBO J. 8: 3773-3779, 1989.
10. Heuertz, R. M., C. A. Piquette, and R. O. Webster. Rabbits with elevated serum C-reactive protein exhibit diminished neutrophil infiltration and vascular permeability in C5a-induced alveolitis. Am. J. Pathol. 142: 319-328, 1993.
11. Heuertz, R. M., D. Xia, D. Samols, and R. O. Webster. Inhibition of C5a des Arg-induced neutrophil alveolitis in transgenic mice expressing C-reactive protein. Am. J. Physiol. 266 (Lung Cell. Mol. Physiol. 10): L649-L654, 1994.
12. Johnson, R. B., Jr., B. B. Keele, Jr., H. P. Misra, J. E. Lehmeyer, L. S. Webb, R. L. Baehner, and K. V. Rajagopalan. The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes. J. Clin. Invest. 55: 1357-1372, 1975.
13. Kaplan, M. H., and J. E. Volanakis. Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. J. Immunol. 112: 2135-2147, 1974.
14. Kew, R. R., T. M. Hyers, and R. O. Webster. Human C-reactive protein inhibits neutrophil chemotaxis in vitro: possible implications for the adult respiratory distress syndrome. J. Lab. Clin. Med. 115: 339-345, 1990.
15. Kilpatrick, J. M., and J. E. Volanakis. Opsonic properties of C-reactive protein: stimulation by phorbol myristate acetate enables human neutrophils to phagocytize C-reactive protein-coated cell. J. Immunol. 134: 3364-33703, 1985.
16. Kushner, I., H. Gewurz, and M. Benson. C-reactive protein and the acute phase response. J. Lab. Clin. Med. 97: 739-749, 1981.
17. Moshage, H. J., H. M. Roelofs, J. F. Van Pelt, P. B. Hazenberg, M. A. Van Leeuwen, P. C. Limburg, L. A. Aarden, and S. H. Yap. The effect of interleukin 1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes. Biochem. Biophys. Res. Commun. 155: 112-117, 1988.
18. Mulligan, M. S., G. O. Till, C. W. Smith, D. C. Anderson, M. Miyasaka, T. Tamatani, R. F. Todd III, T. B. Issekutz, and P. A. Ward. Role of leukocyte adhesion molecules in lung and dermal vascular injury after thermal trauma of skin. Am. J. Pathol. 144: 1008-1015, 1994.
19. Robey, F. A., K. D. Jones, and A. D. Steinberg. C-reactive protein mediates the solubilization of nuclear DNA by complement in vitro. J. Exp. Med. 161: 1344-1356, 1985.
20. Robey, F. A., K. Ohura, S. Futaki, N. Fujii, H. Yajima, N. Goldman, K. D. Jones, and S. Wahl. Proteolysis of human C-reactive protein produces peptides with potent immunomodulating activity. J. Biol. Chem. 262: 7053-7057, 1987.
21. Seeger, W., M. Menger, D. Walmrath, G. Becker, F. Grimminger, and H. Neuhof. Arachidonic acid lipoxygenase pathways and increased vascular permeability in isolated rabbit lungs. Am. Rev. Respir. Dis. 136: 964-972, 1987.
22. Shephard, E. G., R. Anderson, O. Rosen, and M. Fridkin. C-reactive protein peptides inactivate enolase in human neutrophils leading to depletion of intracellular ATP and inhibition of superoxide generation. Immunology 76: 79-80, 1992.
23. Shephard, E. G., R. Anderson, O. Rosen, M. S. Myer, M. Fridkin, A. F. Strachan, and F. C. De Beer. Peptides generated from C-reactive protein by a neutrophil membrane protease. Amino acid sequence and effects of peptides on neutrophil oxidative metabolism and chemotaxis. J. Immunol. 145: 1469-1476, 1990.
24. Shephard, E. G., S. M. Beer, R. Anderson, A. F. Strachan, A. E. Nel, and F. C. De Beer. Generation of biologically active C-reactive protein peptides by a neutral protease on the membrane of phorbol myristate acetate-stimulated neutrophils. J. Immunol. 143: 2974-2981, 1989.
25. Showell, H. J., R. J. Freer, S. H. Zigmond, E. Schiffmann, S. Aswannikumar, B. Corcoran, and E. L. Becker. The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal enzyme secretion for neutrophils. J. Exp. Med. 143: 1154-1169, 1976.
26. Tanaka, H., J. D. Bradley, L. J. Baudendistel, and T. E. Dahms. Mechanisms of increased pulmonary microvascular permeability induced by fMLP in isolated rabbit lungs. J. Appl. Physiol. 73: 2074-2082, 1992.
27. Tanaka, H., J. D. Bradley, L. J. Baudendistel, and T. E. Dahms. Mechanisms of pulmonary vasoconstriction induced by chemotactic peptide fMLP in isolated rabbit lungs. J. Appl. Physiol. 72: 1549-1556, 1992.
28. Voelkel, N. F., K. R. Stenmark, J. T. Reeves, M. M. Maathial, and C. Murphy. Actions of lipoxygenase metabolites in isolated rat lungs. J. Appl. Physiol. 57: 860-867, 1984.
29. 2-integrin expression (Abstract). Am. J. Respir. Crit. Care Med. 149: A232, 1994.
30. Worthen, S. G., P. M. Henson, S. Rowengren, G. P. Downey, and D. M. Hyde. Neutrophils increase volume during migration in vivo and in vitro. Am. J. Respir. Cell Mol. Biol. 10: 1-7, 1994.
31. Zahedi, K., J. M. Tebo, and J. Siripont. Binding of human C-reactive protein to mouse macrophages is mediated by distinct receptors. J. Immunol. 142: 2384-2392, 1989.